CIK 0001703647 · Non-accelerated filer<br>Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472324450
- Phone
- 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Dolan Oliver Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-02-02 | Cerio Jeffrey General Counsel | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2026-02-02 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-12-15 | Chappell Todd Chief Operating Officer | Grant or award | +20,132 | 20,132 | ||
| 2025-12-15 | Vincent Loic A Chief Scientific Officer | Grant or award | +21,715 | 21,715 | ||
| 2025-12-15 | Cerio Jeffrey General Counsel | Grant or award | +41,902 | 41,902 | ||
| 2025-12-15 | Dolan Oliver Senior Vice President, Finance | Grant or award | +21,482 | 21,482 | ||
| 2025-06-11 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +6,010 | 6,010 | ||
| 2025-06-11 | Meyers Rachel Director | Grant or award · Stock Option (Right to Buy) | +6,010 | 6,010 | ||
| 2025-06-11 | Bermingham Nessan Director | Grant or award · Stock Option (Right to Buy) | +6,010 | 6,010 | ||
| 2025-06-11 | Knobil Katharine Director | Grant or award · Stock Option (Right to Buy) | +6,010 | 6,010 | ||
| 2025-06-11 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (Right to Buy) | +6,010 | 6,010 | ||
| 2025-06-11 | PEARSON TIMOTHY R Director | Grant or award · Stock Option (Right to Buy) | +6,010 | 6,010 | ||
| 2025-04-01 | Dolan Oliver Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-04-01 | Vincent Loic A Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2025-02-03 | Cerio Jeffrey General Counsel | Grant or award · Stock Option (Right to Buy) | +29,000 | 29,000 | ||
| 2025-02-03 | Agarwal Vineet Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-02-03 | Aiyar Ram President and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-02-03 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +34,500 | 34,500 | ||
| 2025-02-03 | Olugemo Olukemi Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 |
Page 5 of 10 · 188 trades